• For Individuals
  • For Institutions
  • Download
  • Help

  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
EN
English
简体中文
繁體中文
繁體中文（廣東話）Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials

Event Tracking

Nov7
H.C. Wainwright analyst maintains buy rating on Rani Therapeutics
12:02
Nov6
Rani Therapeutics and Chugai Collaborate and Initiate RT-114 Phase 1 Trial
22:45
Oct28
Rani Therapeutics Director Mir A. Imran Buys $1.25 Million in Stock
02:06
Oct23
Rani Therapeutics Secures $60.3 Million in Oversubscribed Private Placement
20:22
Oct17
Rani Therapeutics Holdings Announces New Loan Agreement
14:07
Aug8
Rani Therapeutics released FY2025 Semi-Annual Earnings on August 7 EST, with actual revenue of USD 172 K and EPS of USD -0.3987
03:00

Schedules & Filings

Schedules
Filings
Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -6.692 M, EPS -0.1831

May13
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 172 K, Net Income -7.264 M, EPS -0.2172

Mar31
Earning Release(EST)

FY2024 Q4 Earning Release (USD) Revenue 1.028 M, Net Income -8.947 M, EPS -0.2739

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MSGM
3.740
+70.78%
+1.550
BKYI
0.9620
+51.57%
+0.327
GIFI
11.780
+49.68%
+3.910
WTGUR
0.2300
+45.11%
+0.071
ORGO
5.630
+44.73%
+1.740
RUBI
0.3136
+39.38%
+0.089
CHEK
1.660
+37.19%
+0.450
GMED
83.890
+35.94%
+22.180
KODK
7.790
+33.16%
+1.940
FEMY
1.040
+33.13%
+0.259
View More
Terms & Conditions
  • Terms of Service
  • Privacy Policy